RA
TWST icon

Rise Advisors’s Twist Bioscience TWST Stock Holding History

Rise Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20
Closed -$686 – 1274
2024
Q1 		$686 Hold
20
– – ﹤0.01% 1200
2023
Q4 		$737 Hold
20
– – ﹤0.01% 542
2023
Q3 		$405 Hold
20
– – ﹤0.01% 593
2023
Q2 		$409 Hold
20
– – ﹤0.01% 629
2023
Q1 		$302 Hold
20
– – ﹤0.01% 765
2022
Q4 		$476 Hold
20
– – ﹤0.01% 715
2022
Q3 		$1K Hold
20
– – ﹤0.01% 684
2022
Q2 		$1K Hold
20
– – ﹤0.01% 683
2022
Q1 		$1K Hold
20
– – ﹤0.01% 640
2021
Q4 		$1.55K Buy
+20
New +$2.05K ﹤0.01% 564

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rise Advisors's TWST Position: Q2 2024 in Review

Rise Advisors sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 20 shares — an estimated $686 sold.

Rise Advisors first reported a position in TWST in Q4 2021 and held it in 10 quarters. The position peaked at $1.55K in Q4 2021. 262 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • Rise Advisors reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
  • Rise Advisors sold 20 Twist Bioscience shares in Q2 2024, an estimated $686.
  • Rise Advisors first reported a position in Twist Bioscience in Q4 2021 and held it in 10 quarters.
  • Rise Advisors's Twist Bioscience position peaked at $1.55K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on Rise Advisors's 13F filing for Q2 2024, filed 9 Jul 2024.